KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Equity: 2019-2025

Historic Return on Equity for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Sep 2025 value amounting to 0.22%.

  • Aurinia Pharmaceuticals' Return on Equity rose 28.00% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 28.00%. This contributed to the annual value of 0.02% for FY2024, which is 21.00% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Return on Equity stood at 0.22%, which was up 25.58% from 0.18% recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Equity peaked at 0.22% during Q3 2025, and registered a low of -0.49% during Q3 2021.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Return on Equity value was -0.14% (recorded in 2024), while the average stood at -0.06%.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Return on Equity fell by 21bps in 2021, and later surged by 32bps in 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Equity (Quarterly) stood at -0.47% in 2021, then grew by 20bps to -0.26% in 2022, then rose by 6bps to -0.20% in 2023, then climbed by 22bps to 0.01% in 2024, then increased by 28bps to 0.22% in 2025.
  • Its Return on Equity stands at 0.22% for Q3 2025, versus 0.18% for Q2 2025 and 0.11% for Q1 2025.